Hui Li
Jiangxi University of Traditional Chinese Medicine(CN)Fujian Medical University(CN)Guangxi Medical University(CN)Cancer Research Institute(US)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Sichuan University(CN)New Generation University College(ET)Zhejiang Cancer Hospital(CN)China Academy of Chinese Medical Sciences(CN)Hangzhou Cancer Hospital(CN)Fujian Agriculture and Forestry University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Lung Cancer Research Studies
Most-Cited Works
- → Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies(2018)205 cited
- → Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production(2018)203 cited
- → Programmed cell death‐1 (PD‐1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell–intrinsic PD‐1(2017)199 cited
- → Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis(2020)186 cited
- → Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR‐141‐mediated NLRP3 inflammasome and TGF‐β1/Smads signaling in diabetic cardiomyopathy(2020)165 cited
- → Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma